Universe Pharmaceuticals Inc (UPC): Cash & Equivalents
Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2021-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report this line under the concept TickerFacts maps.
$8.08M
As of 2021-09-30. As filed; likely tagged in the wrong unit
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2021-09-30 | $8.08M | n/a | 2022-01-31, Balance as of period end |
| 2020-09-30 | $10.06M | n/a | 2022-01-31, Balance as of period end |
| 2019-09-30 | $3.18M | n/a | 2022-01-31, Balance as of period end |